VOLITIONRX LTD — Director's Dealing 2017

Apr 3, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2017-03-30

Reporting Person: Reynolds Cameron John (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-03-30	Stock Option (Right to Buy)	$5	A	100000	Acquired	2023-03-30	Common Stock (100000)	Direct

Footnotes

F1: A total of 100,000 Options were granted on March 30, 2017 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant.